Enovis Corp. completed the acquisition of LimaCorporate S.p.A. a privately held global orthopedic company focused on restoring motion through implants.
Lima strengthens Enovis’ position in the global orthopedic reconstruction market with a portfolio of proven surgical solutions and technologies, which will accelerate global growth and margin expansion, a release stated.
In addition, Lima’s portfolio includes 3D printed Trabecular Titanium implants and a comprehensive revision offering in shoulders, which will further strengthen the company’s position in the extremities market, a release stated.
“We are excited to welcome Lima’s talented team to Enovis. The combination brings Enovis’ recon segment to $1 billion in revenues and creates a fast-growing global orthopedic reconstruction market innovator. This is another great example of how we use strategic acquisitions to accelerate our growth, add great technologies and talent to our company, and drive compounding value for our shareholders,” said Matt Trerotola, CEO of Enovis.
Enovis is a publicly traded company based near Wilmington.
Click on the headline below for earlier story on the acquisition.
